Global Cell Therapy and Tissue Engineering Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cell Therapy and Tissue Engineering Market Size 2017-2028

2.1.2 Cell Therapy and Tissue Engineering Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Cell Therapy and Tissue Engineering Segment by Type

2.2.1 Cell Therapy

2.2.2 Tissue Engineering

2.3 Cell Therapy and Tissue Engineering Market Size by Type

2.3.1 Cell Therapy and Tissue Engineering Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Cell Therapy and Tissue Engineering Market Size Market Share by Type (2017-2022)

2.4 Cell Therapy and Tissue Engineering Segment by Application

2.4.1 Cell Defects

2.4.2 Genetic Diseases

2.4.3 Neurodegenerative Diseases

2.4.4 Tissue Malignancies

2.4.5 Others

2.5 Cell Therapy and Tissue Engineering Market Size by Application

2.5.1 Cell Therapy and Tissue Engineering Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Cell Therapy and Tissue Engineering Market Size Market Share by Application (2017-2022)

3 Cell Therapy and Tissue Engineering Market Size by Player

3.1 Cell Therapy and Tissue Engineering Market Size Market Share by Players

3.1.1 Global Cell Therapy and Tissue Engineering Revenue by Players (2020-2022)

3.1.2 Global Cell Therapy and Tissue Engineering Revenue Market Share by Players (2020-2022)

3.2 Global Cell Therapy and Tissue Engineering Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Cell Therapy and Tissue Engineering by Regions

4.1 Cell Therapy and Tissue Engineering Market Size by Regions (2017-2022)

4.2 Americas Cell Therapy and Tissue Engineering Market Size Growth (2017-2022)

4.3 APAC Cell Therapy and Tissue Engineering Market Size Growth (2017-2022)

4.4 Europe Cell Therapy and Tissue Engineering Market Size Growth (2017-2022)

4.5 Middle East & Africa Cell Therapy and Tissue Engineering Market Size Growth (2017-2022)

5 Americas

5.1 Americas Cell Therapy and Tissue Engineering Market Size by Country (2017-2022)

5.2 Americas Cell Therapy and Tissue Engineering Market Size by Type (2017-2022)

5.3 Americas Cell Therapy and Tissue Engineering Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cell Therapy and Tissue Engineering Market Size by Region (2017-2022)

6.2 APAC Cell Therapy and Tissue Engineering Market Size by Type (2017-2022)

6.3 APAC Cell Therapy and Tissue Engineering Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Cell Therapy and Tissue Engineering by Country (2017-2022)

7.2 Europe Cell Therapy and Tissue Engineering Market Size by Type (2017-2022)

7.3 Europe Cell Therapy and Tissue Engineering Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cell Therapy and Tissue Engineering by Region (2017-2022)

8.2 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Type (2017-2022)

8.3 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Cell Therapy and Tissue Engineering Market Forecast

10.1 Global Cell Therapy and Tissue Engineering Forecast by Regions (2023-2028)

10.1.1 Global Cell Therapy and Tissue Engineering Forecast by Regions (2023-2028)

10.1.2 Americas Cell Therapy and Tissue Engineering Forecast

10.1.3 APAC Cell Therapy and Tissue Engineering Forecast

10.1.4 Europe Cell Therapy and Tissue Engineering Forecast

10.1.5 Middle East & Africa Cell Therapy and Tissue Engineering Forecast

10.2 Americas Cell Therapy and Tissue Engineering Forecast by Country (2023-2028)

10.2.1 United States Cell Therapy and Tissue Engineering Market Forecast

10.2.2 Canada Cell Therapy and Tissue Engineering Market Forecast

10.2.3 Mexico Cell Therapy and Tissue Engineering Market Forecast

10.2.4 Brazil Cell Therapy and Tissue Engineering Market Forecast

10.3 APAC Cell Therapy and Tissue Engineering Forecast by Region (2023-2028)

10.3.1 China Cell Therapy and Tissue Engineering Market Forecast

10.3.2 Japan Cell Therapy and Tissue Engineering Market Forecast

10.3.3 Korea Cell Therapy and Tissue Engineering Market Forecast

10.3.4 Southeast Asia Cell Therapy and Tissue Engineering Market Forecast

10.3.5 India Cell Therapy and Tissue Engineering Market Forecast

10.3.6 Australia Cell Therapy and Tissue Engineering Market Forecast

10.4 Europe Cell Therapy and Tissue Engineering Forecast by Country (2023-2028)

10.4.1 Germany Cell Therapy and Tissue Engineering Market Forecast

10.4.2 France Cell Therapy and Tissue Engineering Market Forecast

10.4.3 UK Cell Therapy and Tissue Engineering Market Forecast

10.4.4 Italy Cell Therapy and Tissue Engineering Market Forecast

10.4.5 Russia Cell Therapy and Tissue Engineering Market Forecast

10.5 Middle East & Africa Cell Therapy and Tissue Engineering Forecast by Region (2023-2028)

10.5.1 Egypt Cell Therapy and Tissue Engineering Market Forecast

10.5.2 South Africa Cell Therapy and Tissue Engineering Market Forecast

10.5.3 Israel Cell Therapy and Tissue Engineering Market Forecast

10.5.4 Turkey Cell Therapy and Tissue Engineering Market Forecast

10.5.5 GCC Countries Cell Therapy and Tissue Engineering Market Forecast

10.6 Global Cell Therapy and Tissue Engineering Forecast by Type (2023-2028)

10.7 Global Cell Therapy and Tissue Engineering Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Betalin Therapeutics

11.1.1 Betalin Therapeutics Company Information

11.1.2 Betalin Therapeutics Cell Therapy and Tissue Engineering Product Offered

11.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Betalin Therapeutics Main Business Overview

11.1.5 Betalin Therapeutics Latest Developments

11.2 BioCardia, Inc

11.2.1 BioCardia, Inc Company Information

11.2.2 BioCardia, Inc Cell Therapy and Tissue Engineering Product Offered

11.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 BioCardia, Inc Main Business Overview

11.2.5 BioCardia, Inc Latest Developments

11.3 BioReliance Corporation

11.3.1 BioReliance Corporation Company Information

11.3.2 BioReliance Corporation Cell Therapy and Tissue Engineering Product Offered

11.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 BioReliance Corporation Main Business Overview

11.3.5 BioReliance Corporation Latest Developments

11.4 Biosolution Co.

11.4.1 Biosolution Co. Company Information

11.4.2 Biosolution Co. Cell Therapy and Tissue Engineering Product Offered

11.4.3 Biosolution Co. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Biosolution Co. Main Business Overview

11.4.5 Biosolution Co. Latest Developments

11.5 Brainstorm Cell Therapeutics, Inc

11.5.1 Brainstorm Cell Therapeutics, Inc Company Information

11.5.2 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offered

11.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Brainstorm Cell Therapeutics, Inc Main Business Overview

11.5.5 Brainstorm Cell Therapeutics, Inc Latest Developments

11.6 MaxCyte, Inc

11.6.1 MaxCyte, Inc Company Information

11.6.2 MaxCyte, Inc Cell Therapy and Tissue Engineering Product Offered

11.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 MaxCyte, Inc Main Business Overview

11.6.5 MaxCyte, Inc Latest Developments

11.7 Medigene AG

11.7.1 Medigene AG Company Information

11.7.2 Medigene AG Cell Therapy and Tissue Engineering Product Offered

11.7.3 Medigene AG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Medigene AG Main Business Overview

11.7.5 Medigene AG Latest Developments

11.8 MEDIPOST CO.

11.8.1 MEDIPOST CO. Company Information

11.8.2 MEDIPOST CO. Cell Therapy and Tissue Engineering Product Offered

11.8.3 MEDIPOST CO. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 MEDIPOST CO. Main Business Overview

11.8.5 MEDIPOST CO. Latest Developments

11.9 Mesoblast Limited

11.9.1 Mesoblast Limited Company Information

11.9.2 Mesoblast Limited Cell Therapy and Tissue Engineering Product Offered

11.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Mesoblast Limited Main Business Overview

11.9.5 Mesoblast Limited Latest Developments

11.10 Miromatrix Medical, Inc.

11.10.1 Miromatrix Medical, Inc. Company Information

11.10.2 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Product Offered

11.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Miromatrix Medical, Inc. Main Business Overview

11.10.5 Miromatrix Medical, Inc. Latest Developments

11.11 MolMed S.p.A

11.11.1 MolMed S.p.A Company Information

11.11.2 MolMed S.p.A Cell Therapy and Tissue Engineering Product Offered

11.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 MolMed S.p.A Main Business Overview

11.11.5 MolMed S.p.A Latest Developments

11.12 Mustang Bio, Inc

11.12.1 Mustang Bio, Inc Company Information

11.12.2 Mustang Bio, Inc Cell Therapy and Tissue Engineering Product Offered

11.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Mustang Bio, Inc Main Business Overview

11.12.5 Mustang Bio, Inc Latest Developments

11.13 NantKwest, Inc.

11.13.1 NantKwest, Inc. Company Information

11.13.2 NantKwest, Inc. Cell Therapy and Tissue Engineering Product Offered

11.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 NantKwest, Inc. Main Business Overview

11.13.5 NantKwest, Inc. Latest Developments

11.14 Neuralstem, Inc

11.14.1 Neuralstem, Inc Company Information

11.14.2 Neuralstem, Inc Cell Therapy and Tissue Engineering Product Offered

11.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Neuralstem, Inc Main Business Overview

11.14.5 Neuralstem, Inc Latest Developments

11.15 NexImmune, Inc.

11.15.1 NexImmune, Inc. Company Information

11.15.2 NexImmune, Inc. Cell Therapy and Tissue Engineering Product Offered

11.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 NexImmune, Inc. Main Business Overview

11.15.5 NexImmune, Inc. Latest Developments

11.16 Nohla Therapeutics, Inc

11.16.1 Nohla Therapeutics, Inc Company Information

11.16.2 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offered

11.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Nohla Therapeutics, Inc Main Business Overview

11.16.5 Nohla Therapeutics, Inc Latest Developments

11.17 ReNeuron Group plc

11.17.1 ReNeuron Group plc Company Information

11.17.2 ReNeuron Group plc Cell Therapy and Tissue Engineering Product Offered

11.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 ReNeuron Group plc Main Business Overview

11.17.5 ReNeuron Group plc Latest Developments

11.18 Richter-Helm BioLogics GmbH & Co. KG

11.18.1 Richter-Helm BioLogics GmbH & Co. KG Company Information

11.18.2 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product Offered

11.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Richter-Helm BioLogics GmbH & Co. KG Main Business Overview

11.18.5 Richter-Helm BioLogics GmbH & Co. KG Latest Developments

11.19 RoosterBio, Inc

11.19.1 RoosterBio, Inc Company Information

11.19.2 RoosterBio, Inc Cell Therapy and Tissue Engineering Product Offered

11.19.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 RoosterBio, Inc Main Business Overview

11.19.5 RoosterBio, Inc Latest Developments

11.20 RoslinCT

11.20.1 RoslinCT Company Information

11.20.2 RoslinCT Cell Therapy and Tissue Engineering Product Offered

11.20.3 RoslinCT Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 RoslinCT Main Business Overview

11.20.5 RoslinCT Latest Developments

11.21 Rubius Therapeutics, Inc.

11.21.1 Rubius Therapeutics, Inc. Company Information

11.21.2 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Offered

11.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.21.4 Rubius Therapeutics, Inc. Main Business Overview

11.21.5 Rubius Therapeutics, Inc. Latest Developments

11.22 Sangamo Therapeutics, Inc

11.22.1 Sangamo Therapeutics, Inc Company Information

11.22.2 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offered

11.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.22.4 Sangamo Therapeutics, Inc Main Business Overview

11.22.5 Sangamo Therapeutics, Inc Latest Developments

11.23 Voyager Therapeutics, Inc

11.23.1 Voyager Therapeutics, Inc Company Information

11.23.2 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offered

11.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.23.4 Voyager Therapeutics, Inc Main Business Overview

11.23.5 Voyager Therapeutics, Inc Latest Developments

11.24 Waisman Biomanufacturing

11.24.1 Waisman Biomanufacturing Company Information

11.24.2 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Product Offered

11.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.24.4 Waisman Biomanufacturing Main Business Overview

11.24.5 Waisman Biomanufacturing Latest Developments

11.25 WindMIL Therapeutics, Inc.

11.25.1 WindMIL Therapeutics, Inc. Company Information

11.25.2 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Offered

11.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.25.4 WindMIL Therapeutics, Inc. Main Business Overview

11.25.5 WindMIL Therapeutics, Inc. Latest Developments

11.26 Wuxi App Tec, Inc.

11.26.1 Wuxi App Tec, Inc. Company Information

11.26.2 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Product Offered

11.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.26.4 Wuxi App Tec, Inc. Main Business Overview

11.26.5 Wuxi App Tec, Inc. Latest Developments

11.27 ReNeuron Group plc

11.27.1 ReNeuron Group plc Company Information

11.27.2 ReNeuron Group plc Cell Therapy and Tissue Engineering Product Offered

11.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.27.4 ReNeuron Group plc Main Business Overview

11.27.5 ReNeuron Group plc Latest Developments

11.28 Richter-Helm BioLogics GmbH & Co. KG

11.28.1 Richter-Helm BioLogics GmbH & Co. KG Company Information

11.28.2 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product Offered

11.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.28.4 Richter-Helm BioLogics GmbH & Co. KG Main Business Overview

11.28.5 Richter-Helm BioLogics GmbH & Co. KG Latest Developments

11.29 RoosterBio, Inc

11.29.1 RoosterBio, Inc Company Information

11.29.2 RoosterBio, Inc Cell Therapy and Tissue Engineering Product Offered

11.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.29.4 RoosterBio, Inc Main Business Overview

11.29.5 RoosterBio, Inc Latest Developments

11.30 RoslinCT

11.30.1 RoslinCT Company Information

11.30.2 RoslinCT Cell Therapy and Tissue Engineering Product Offered

11.30.3 RoslinCT Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2020-2022)

11.30.4 RoslinCT Main Business Overview

11.30.5 RoslinCT Latest Developments

12 Research Findings and Conclusion

Table 1. Cell Therapy and Tissue Engineering Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Cell Therapy

Table 3. Major Players of Tissue Engineering

Table 4. Cell Therapy and Tissue Engineering Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Cell Therapy and Tissue Engineering Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Cell Therapy and Tissue Engineering Market Size Market Share by Type (2017-2022)

Table 7. Cell Therapy and Tissue Engineering Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Cell Therapy and Tissue Engineering Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Cell Therapy and Tissue Engineering Market Size Market Share by Application (2017-2022)

Table 10. Global Cell Therapy and Tissue Engineering Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Cell Therapy and Tissue Engineering Revenue Market Share by Player (2020-2022)

Table 12. Cell Therapy and Tissue Engineering Key Players Head office and Products Offered

Table 13. Cell Therapy and Tissue Engineering Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Cell Therapy and Tissue Engineering Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Cell Therapy and Tissue Engineering Market Size Market Share by Regions (2017-2022)

Table 18. Americas Cell Therapy and Tissue Engineering Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Cell Therapy and Tissue Engineering Market Size Market Share by Country (2017-2022)

Table 20. Americas Cell Therapy and Tissue Engineering Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Cell Therapy and Tissue Engineering Market Size Market Share by Type (2017-2022)

Table 22. Americas Cell Therapy and Tissue Engineering Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Cell Therapy and Tissue Engineering Market Size Market Share by Application (2017-2022)

Table 24. APAC Cell Therapy and Tissue Engineering Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Cell Therapy and Tissue Engineering Market Size Market Share by Region (2017-2022)

Table 26. APAC Cell Therapy and Tissue Engineering Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Cell Therapy and Tissue Engineering Market Size Market Share by Type (2017-2022)

Table 28. APAC Cell Therapy and Tissue Engineering Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Cell Therapy and Tissue Engineering Market Size Market Share by Application (2017-2022)

Table 30. Europe Cell Therapy and Tissue Engineering Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Cell Therapy and Tissue Engineering Market Size Market Share by Country (2017-2022)

Table 32. Europe Cell Therapy and Tissue Engineering Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Cell Therapy and Tissue Engineering Market Size Market Share by Type (2017-2022)

Table 34. Europe Cell Therapy and Tissue Engineering Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Cell Therapy and Tissue Engineering Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Cell Therapy and Tissue Engineering Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Cell Therapy and Tissue Engineering Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Cell Therapy and Tissue Engineering Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Cell Therapy and Tissue Engineering

Table 43. Key Market Challenges & Risks of Cell Therapy and Tissue Engineering

Table 44. Key Industry Trends of Cell Therapy and Tissue Engineering

Table 45. Global Cell Therapy and Tissue Engineering Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Cell Therapy and Tissue Engineering Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Cell Therapy and Tissue Engineering Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Cell Therapy and Tissue Engineering Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Cell Therapy and Tissue Engineering Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Cell Therapy and Tissue Engineering Market Size Market Share Forecast by Application (2023-2028)

Table 51. Betalin Therapeutics Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 52. Betalin Therapeutics Cell Therapy and Tissue Engineering Product Offered

Table 53. Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Betalin Therapeutics Main Business

Table 55. Betalin Therapeutics Latest Developments

Table 56. BioCardia, Inc Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 57. BioCardia, Inc Cell Therapy and Tissue Engineering Product Offered

Table 58. BioCardia, Inc Main Business

Table 59. BioCardia, Inc Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. BioCardia, Inc Latest Developments

Table 61. BioReliance Corporation Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 62. BioReliance Corporation Cell Therapy and Tissue Engineering Product Offered

Table 63. BioReliance Corporation Main Business

Table 64. BioReliance Corporation Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. BioReliance Corporation Latest Developments

Table 66. Biosolution Co. Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 67. Biosolution Co. Cell Therapy and Tissue Engineering Product Offered

Table 68. Biosolution Co. Main Business

Table 69. Biosolution Co. Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Biosolution Co. Latest Developments

Table 71. Brainstorm Cell Therapeutics, Inc Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 72. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offered

Table 73. Brainstorm Cell Therapeutics, Inc Main Business

Table 74. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Brainstorm Cell Therapeutics, Inc Latest Developments

Table 76. MaxCyte, Inc Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 77. MaxCyte, Inc Cell Therapy and Tissue Engineering Product Offered

Table 78. MaxCyte, Inc Main Business

Table 79. MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. MaxCyte, Inc Latest Developments

Table 81. Medigene AG Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 82. Medigene AG Cell Therapy and Tissue Engineering Product Offered

Table 83. Medigene AG Main Business

Table 84. Medigene AG Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Medigene AG Latest Developments

Table 86. MEDIPOST CO. Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 87. MEDIPOST CO. Cell Therapy and Tissue Engineering Product Offered

Table 88. MEDIPOST CO. Main Business

Table 89. MEDIPOST CO. Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. MEDIPOST CO. Latest Developments

Table 91. Mesoblast Limited Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 92. Mesoblast Limited Cell Therapy and Tissue Engineering Product Offered

Table 93. Mesoblast Limited Main Business

Table 94. Mesoblast Limited Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Mesoblast Limited Latest Developments

Table 96. Miromatrix Medical, Inc. Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 97. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Product Offered

Table 98. Miromatrix Medical, Inc. Main Business

Table 99. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Miromatrix Medical, Inc. Latest Developments

Table 101. MolMed S.p.A Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 102. MolMed S.p.A Cell Therapy and Tissue Engineering Product Offered

Table 103. MolMed S.p.A Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. MolMed S.p.A Main Business

Table 105. MolMed S.p.A Latest Developments

Table 106. Mustang Bio, Inc Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 107. Mustang Bio, Inc Cell Therapy and Tissue Engineering Product Offered

Table 108. Mustang Bio, Inc Main Business

Table 109. Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Mustang Bio, Inc Latest Developments

Table 111. NantKwest, Inc. Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 112. NantKwest, Inc. Cell Therapy and Tissue Engineering Product Offered

Table 113. NantKwest, Inc. Main Business

Table 114. NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. NantKwest, Inc. Latest Developments

Table 116. Neuralstem, Inc Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 117. Neuralstem, Inc Cell Therapy and Tissue Engineering Product Offered

Table 118. Neuralstem, Inc Main Business

Table 119. Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Neuralstem, Inc Latest Developments

Table 121. NexImmune, Inc. Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 122. NexImmune, Inc. Cell Therapy and Tissue Engineering Product Offered

Table 123. NexImmune, Inc. Main Business

Table 124. NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. NexImmune, Inc. Latest Developments

Table 126. Nohla Therapeutics, Inc Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 127. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offered

Table 128. Nohla Therapeutics, Inc Main Business

Table 129. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 130. Nohla Therapeutics, Inc Latest Developments

Table 131. ReNeuron Group plc Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 132. ReNeuron Group plc Cell Therapy and Tissue Engineering Product Offered

Table 133. ReNeuron Group plc Main Business

Table 134. ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 135. ReNeuron Group plc Latest Developments

Table 136. Richter-Helm BioLogics GmbH & Co. KG Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 137. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product Offered

Table 138. Richter-Helm BioLogics GmbH & Co. KG Main Business

Table 139. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 140. Richter-Helm BioLogics GmbH & Co. KG Latest Developments

Table 141. RoosterBio, Inc Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 142. RoosterBio, Inc Cell Therapy and Tissue Engineering Product Offered

Table 143. RoosterBio, Inc Main Business

Table 144. RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 145. RoosterBio, Inc Latest Developments

Table 146. RoslinCT Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 147. RoslinCT Cell Therapy and Tissue Engineering Product Offered

Table 148. RoslinCT Main Business

Table 149. RoslinCT Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 150. RoslinCT Latest Developments

Table 151. Rubius Therapeutics, Inc. Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 152. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Offered

Table 153. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 154. Rubius Therapeutics, Inc. Main Business

Table 155. Rubius Therapeutics, Inc. Latest Developments

Table 156. Sangamo Therapeutics, Inc Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 157. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offered

Table 158. Sangamo Therapeutics, Inc Main Business

Table 159. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 160. Sangamo Therapeutics, Inc Latest Developments

Table 161. Voyager Therapeutics, Inc Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 162. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offered

Table 163. Voyager Therapeutics, Inc Main Business

Table 164. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 165. Voyager Therapeutics, Inc Latest Developments

Table 166. Waisman Biomanufacturing Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 167. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Product Offered

Table 168. Waisman Biomanufacturing Main Business

Table 169. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 170. Waisman Biomanufacturing Latest Developments

Table 171. WindMIL Therapeutics, Inc. Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 172. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Offered

Table 173. WindMIL Therapeutics, Inc. Main Business

Table 174. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 175. WindMIL Therapeutics, Inc. Latest Developments

Table 176. Wuxi App Tec, Inc. Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 177. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Product Offered

Table 178. Wuxi App Tec, Inc. Main Business

Table 179. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 180. Wuxi App Tec, Inc. Latest Developments

Table 181. ReNeuron Group plc Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 182. ReNeuron Group plc Cell Therapy and Tissue Engineering Product Offered

Table 183. ReNeuron Group plc Main Business

Table 184. ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 185. ReNeuron Group plc Latest Developments

Table 186. Richter-Helm BioLogics GmbH & Co. KG Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 187. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product Offered

Table 188. Richter-Helm BioLogics GmbH & Co. KG Main Business

Table 189. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 190. Richter-Helm BioLogics GmbH & Co. KG Latest Developments

Table 191. RoosterBio, Inc Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 192. RoosterBio, Inc Cell Therapy and Tissue Engineering Product Offered

Table 193. RoosterBio, Inc Main Business

Table 194. RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 195. RoosterBio, Inc Latest Developments

Table 196. RoslinCT Details, Company Type, Cell Therapy and Tissue Engineering Area Served and Its Competitors

Table 197. RoslinCT Cell Therapy and Tissue Engineering Product Offered

Table 198. RoslinCT Main Business

Table 199. RoslinCT Cell Therapy and Tissue Engineering Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 200. RoslinCT Latest Developments

List of Figures

Figure 1. Cell Therapy and Tissue Engineering Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Cell Therapy and Tissue Engineering Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Cell Therapy and Tissue Engineering Market Size Market Share by Type in 2021

Figure 7. Cell Therapy and Tissue Engineering in Cell Defects

Figure 8. Global Cell Therapy and Tissue Engineering Market: Cell Defects (2017-2022) & ($ Millions)

Figure 9. Cell Therapy and Tissue Engineering in Genetic Diseases

Figure 10. Global Cell Therapy and Tissue Engineering Market: Genetic Diseases (2017-2022) & ($ Millions)

Figure 11. Cell Therapy and Tissue Engineering in Neurodegenerative Diseases

Figure 12. Global Cell Therapy and Tissue Engineering Market: Neurodegenerative Diseases (2017-2022) & ($ Millions)

Figure 13. Cell Therapy and Tissue Engineering in Tissue Malignancies

Figure 14. Global Cell Therapy and Tissue Engineering Market: Tissue Malignancies (2017-2022) & ($ Millions)

Figure 15. Cell Therapy and Tissue Engineering in Others

Figure 16. Global Cell Therapy and Tissue Engineering Market: Others (2017-2022) & ($ Millions)

Figure 17. Global Cell Therapy and Tissue Engineering Market Size Market Share by Application in 2021

Figure 18. Global Cell Therapy and Tissue Engineering Revenue Market Share by Player in 2021

Figure 19. Global Cell Therapy and Tissue Engineering Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Cell Therapy and Tissue Engineering Market Size 2017-2022 ($ Millions)

Figure 21. APAC Cell Therapy and Tissue Engineering Market Size 2017-2022 ($ Millions)

Figure 22. Europe Cell Therapy and Tissue Engineering Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Cell Therapy and Tissue Engineering Market Size 2017-2022 ($ Millions)

Figure 24. Americas Cell Therapy and Tissue Engineering Value Market Share by Country in 2021

Figure 25. Americas Cell Therapy and Tissue Engineering Consumption Market Share by Type in 2021

Figure 26. Americas Cell Therapy and Tissue Engineering Market Size Market Share by Application in 2021

Figure 27. United States Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Cell Therapy and Tissue Engineering Market Size Market Share by Region in 2021

Figure 32. APAC Cell Therapy and Tissue Engineering Market Size Market Share by Application in 2021

Figure 33. China Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Cell Therapy and Tissue Engineering Market Size Market Share by Country in 2021

Figure 40. Europe Cell Therapy and Tissue Engineering Market Size Market Share by Type in 2021

Figure 41. Europe Cell Therapy and Tissue Engineering Market Size Market Share by Application in 2021

Figure 42. Germany Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Cell Therapy and Tissue Engineering Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Cell Therapy and Tissue Engineering Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Cell Therapy and Tissue Engineering Market Size Market Share by Application in 2021

Figure 50. Egypt Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Cell Therapy and Tissue Engineering Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 56. APAC Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 57. Europe Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 59. United States Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 60. Canada Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 63. China Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 64. Japan Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 65. Korea Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 67. India Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 68. Australia Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 69. Germany Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 70. France Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 71. UK Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 72. Italy Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 73. Russia Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 74. Spain Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 77. Israel Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Cell Therapy and Tissue Engineering Market Size 2023-2028 ($ Millions)